teaser
European regulators have expanded the number of patients eligible for treatment with GlaxoSmithKline’s chronic obstructive pulmonary disorder drug Seretide
Published on 10 July 2007
COPD drug access widened
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine